FISIOLOGÍA Y FARMACOLOGÍA
Department
Jorge
Cannata Andía
Publications by the researcher in collaboration with Jorge Cannata Andía (12)
2023
2022
-
RICORS2040: The need for collaborative research in chronic kidney disease
Clinical Kidney Journal, Vol. 15, Núm. 3, pp. 372-387
2019
-
Barley-ß-glucans reduce systemic inflammation, renal injury and aortic calcification through ADAM17 and neutral-sphingomyelinase2 inhibition
Scientific Reports, Vol. 9, Núm. 1
2018
-
Risk of hospitalization associated with body mass index and weight changes among prevalent haemodialysis patients
Nefrologia, Vol. 38, Núm. 5, pp. 520-527
2017
-
Regulation of miR-29b and miR-30c by vitamin D receptor activators contributes to attenuate uraemia-induced cardiac fibrosis
Nephrology Dialysis Transplantation, Vol. 32, Núm. 11, pp. 1831-1840
2016
-
Direct inhibition of osteoblastic Wnt pathway by fibroblast growth factor 23 contributes to bone loss in chronic kidney disease
Kidney International, Vol. 90, Núm. 1, pp. 77-89
-
Lamin A is involved in the development of vascular calcification induced by chronic kidney failure and phosphorus load
Bone, Vol. 84, pp. 160-168
2015
-
Plasma cardiotrophin-1 as a marker of hypertension and diabetes-induced target organ damage and cardiovascular risk
Medicine (United States), Vol. 94, Núm. 30
2013
-
Influence of body mass index on the association of weight changes with mortality in hemodialysis patients
Clinical Journal of the American Society of Nephrology, Vol. 8, Núm. 10, pp. 1725-1733
2011
-
Necrotic concentrations of cisplatin activate the apoptotic machinery but inhibit effector caspases and interfere with the execution of apoptosis
Toxicological Sciences, Vol. 122, Núm. 1, pp. 73-85
2010
-
Differential effects of 17β-estradiol and raloxifene on bone and lipid metabolism in rats with chronic kidney disease and estrogen insufficiency
Menopause, Vol. 17, Núm. 4, pp. 766-771
-
New therapies: Calcimimetics, phosphate binders and vitamin D receptor activators
Pediatric Nephrology